Montpellier, France

Jacqueline Lansen


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1982-1987

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jacqueline Lansen: Innovator in Therapeutic Applications

Introduction

Jacqueline Lansen is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of therapeutics, particularly through her innovative work on xylan sulfates. With a total of 3 patents to her name, Lansen's inventions focus on the preparation and application of these compounds as therapeutic agents.

Latest Patents

Lansen's latest patents include "Xylan sulfates of low molecular weight, process for their preparation." This invention relates to novel xylan sulfates with an average molecular weight between 2000 and 5000 Daltons. The patent also details a process for their preparation by fractionation and their use in therapeutics as orally active antithrombotic and hypolipidemic agents. Another significant patent is "Xylane sulfates, process for their preparation, and anti-thrombosis." This invention introduces new xylane sulfates with an apparent molar weight between 7000 and 12000, along with a process for their preparation and therapeutic applications as anti-thrombosis and hypolipidemic agents.

Career Highlights

Throughout her career, Jacqueline Lansen has worked with notable companies such as Sanofi and C M Industries. Her work in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in therapeutic applications.

Collaborations

Lansen has collaborated with esteemed colleagues, including Alain Bayol and Jean-Marie Pereillo. These partnerships have further enriched her research and development efforts in the field.

Conclusion

Jacqueline Lansen's contributions to the field of therapeutics through her patents on xylan sulfates highlight her innovative spirit and dedication to advancing medical science. Her work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…